- Home
- AMBC vs SION Comparison
AMBC vs SION Comparison
Compare AMBC & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- SION
- Stock Information
- Founded
- AMBC 1971
- SION 2019
- Country
- AMBC United States
- SION United States
- Employees
- AMBC N/A
- SION N/A
- Industry
- AMBC Property-Casualty Insurers
- SION
- Sector
- AMBC Finance
- SION
- Exchange
- AMBC Nasdaq
- SION NYSE
- Market Cap
- AMBC 388.0M
- SION 338.0M
- IPO Year
- AMBC 1991
- SION 2025
- Fundamental
- Price
- AMBC $7.31
- SION $11.07
- Analyst Decision
- AMBC Strong Buy
- SION Strong Buy
- Analyst Count
- AMBC 2
- SION 1
- Target Price
- AMBC $17.00
- SION $32.00
- AVG Volume (30 Days)
- AMBC 1.6M
- SION 225.5K
- Earning Date
- AMBC 05-05-2025
- SION 05-25-2025
- Dividend Yield
- AMBC N/A
- SION N/A
- EPS Growth
- AMBC N/A
- SION N/A
- EPS
- AMBC N/A
- SION N/A
- Revenue
- AMBC $240,754,000.00
- SION N/A
- Revenue This Year
- AMBC N/A
- SION N/A
- Revenue Next Year
- AMBC N/A
- SION N/A
- P/E Ratio
- AMBC N/A
- SION N/A
- Revenue Growth
- AMBC 90.76
- SION N/A
- 52 Week Low
- AMBC $6.33
- SION $7.26
- 52 Week High
- AMBC $18.45
- SION $25.19
- Technical
- Relative Strength Index (RSI)
- AMBC 39.40
- SION N/A
- Support Level
- AMBC $6.41
- SION N/A
- Resistance Level
- AMBC $7.08
- SION N/A
- Average True Range (ATR)
- AMBC 0.46
- SION 0.00
- MACD
- AMBC 0.05
- SION 0.00
- Stochastic Oscillator
- AMBC 38.58
- SION 0.00
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.